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Abstract
Background: Anemia is pervasive among children under the age of two years in Bangladesh. This study aimed to
assess the effect of daily supplementation of multiple micronutrient powder (MNP) for 2 months and 4 months
primarily on hemoglobin status of children aged 6–23 months living in a slum of Dhaka, Bangladesh.
Methods: It was a community-based observational study where a total of 402 children and 578 children were
enrolled for 2 months and 4 months MNP supplementation respectively. Venous blood was collected at enrollment
and 5 months later. Hemoglobin level was measured and morbidity episodes recorded from twice weekly home
visits.
Results: At enrollment, hemoglobin levels were 10.57 ± 1.28 g/dl and 10.78 ± 1.35 g/dl across 2 months and
4 months MNP supplementation groups respectively, compared to 10.65 ± 1.36 g/dl and 11.14 ± 1.11 g/dl at the
end-line after MNP supplementation. Plasma hemoglobin increased only after 4 months supplementation
in difference-in-difference analysis and this was significantly more in younger children after adjusting the
confounding variables (p = 0.03). Prevalence of anemia had improved for both at 2 months (p = 0.015) and
4 months (p = 0.004) of MNP supplementation. Incidence rate ratios (IRR) for diarrhea, cough and fever were
comparable across the groups during the supplementation periods and IRR for acute lower respiratory tract
infection was significantly lower in 4 months supplementation group with a IRR of 0.30 (95 % CI; 0.22, 0.42).
Conclusion: Four months MNP supplementation was relatively more effective in improving hemoglobin level
in children 6–24 months.
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Background
Globally 270 million children under the age of 5 years
are affected by anemia with highest prevalence in devel-
oping countries [1]. Anemia is prevalent among all age
groups in Bangladesh especially among 6–23 month old
children (62.5 %–78.7 %) [2]. According to World Health
Organization (WHO), anemia prevalence of 40 % or more
in any population is considered as a severe public health
problem [3]. The alarmingly high prevalence of anemia
among children, coupled with its associated adverse
health, development and economic consequences high-
lights the need for intensified actions to address this
ongoing public health problem. Iron deficiency, as defined
by specific biochemical tests, is the most common cause
of anemia in most parts of the world [4].
In developing countries, only a small fraction of the
recommended daily iron requirement comes from com-
plementary foods, and most of the consumed iron is of
plant origin which absorbs less in the body than animal
source iron, which together with the lack of any additional
supplementation causes a large number of children to
suffer from iron deficiency [5–8]. However, in recent
years, home fortification of complementary foods with
multiple micronutrient powders (MNP) has been proven
to be the most effective and cost-efficient strategy to
reduce iron deficiency and hence combat anemia in com-
parison to other interventions [9–12]. Two systematic
reviews have concluded that MNP is as effective as iron
drops in improving hemoglobin status and reduction of
anemia. MNP supplementation also had better acceptance
than iron drops among children and exhibits fewer side
effects [9, 10]. The latest Cochrane review on the effects
and safety of home fortification of foods with MNP in
children under 2 implies that the use of MNP in home
fortification of food resulted in reduction of anemia by
31 % [13]. Regarding the frequency and duration of MNP
supplementation, the home fortification technical advisory
group of WHO recommended that 60–180 sachets of
MNP sachets should be made available to target groups
(children 6–23 months) over a period of 6 months [14].
However, data on optimum duration for MNP supplemen-
tation is still uncertain for countries like Bangladesh, par-
ticularly in slum settings.
This current analysis took the opportunity of Malnutrition-
Enteric disease (MAL-ED) study [15], where children were
provided with daily MNP supplementation in a slum set-
ting of Dhaka city [16]. The primary aim of this study was
to evaluate the relative efficacy of MNP served for two
and four months period on improving plasma hemoglobin
level among 6–24 months old children. This study also
investigated the morbidity episodes during the MNP sup-
plementation period and also compared the morbidity
episodes with a group of children of same age from the
same community without MNP supplementation.
Methods
This observational study was performed within the on-
going study of Etiology, Risk Factors, and Interactions
of Enteric Infections and Malnutrition and the Conse-
quences for Child Health (MAL-ED). The MAL-ED
study is a multi-country study focused on gaining a
better understanding of the risk factors contributing
to malnutrition and enteric diseases and their associ-
ated health consequences in children of developing
countries [15]. In Bangladesh, the study is being con-
ducted among residents of an under-privileged urban
community in Bauniabad slum in Mirpur, Dhaka [16]. As
per the icddr,b institutional review board approved proto-
col of MAL-ED study in Dhaka, MNP was provided to all
study children for 2 months considering the high preva-
lence of childhood anemia in Bangladesh. However, in-
terim results showed that the anemia reduction was less
than it was previously anticipated. Considering the success
stories of longer duration MNP supplementation in Ghana
and Cambodian MNP trials [17, 18], we decided to con-
tinue to provide MNP supplementation for an additional
2 months for the rest of the children. MNP was provided
in sachets, with daily allowance of one sachet per child,
6 days a week for either 2 months or 4 months to all
participating children. The first child was enrolled on
November 15, 2009 and the last child on December 18,
2012.
Each sachet of MNP contained: 12.5 mg iron, 5 mg
zinc, 300 μg vitamin A, 150 μg folic acid, and 50 mg of
vitamin C. MNP sachets were distributed among the
children when they attended 6 days a week one of the
four feeding outposts established for the study within
the slum. The caregivers (mother, grandmother or an
older sibling) were asked to feed the children MNP by
sprinkling the sachet contents over their first one or two
servings of offered food, during the feeding sessions at
the outposts. The research staff directly observed and
recorded consumption of MNP by the children.
Biological sample collection and laboratory testing
Five ml of venous blood was collected from enrolled
children at enrollment and 5 months. Hemoglobin (Hb)
level was tested. Hb was measured by direct cyanmethe-
moglobin method [19] at the Nutritional Biochemistry
Laboratory of icddr,b.
Collection of morbidity data
Morbidity episodes of the participants during the study
period were collected through active surveillance where
health workers recorded all morbidity episodes by vis-
iting each home twice a week for 5 months from
enrollment.
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Study participants included in analysis
A total of 1,123 children were eligible for the study and
980 children were enrolled. During the course of the
study, 172 (17.6 %) children were lost to follow up and
808 children completed the study. Among the children
who were lost to follow-up, 98 moved out from the
study site, 50 decided to withdraw from the study as
their parents did not want them to provide blood and 21
left the study without any known reasons. Three children
died during the course of the study and deaths of three
participants were not linked with any activities of the
study. One child died from complication of Acute Myeloid
Leukemia (AML), and other two children were suffering
from severe acute malnutrition (SAM). The SAM children
died during their visit to their grandfather’s houses at rural
districts where they had developed bronco-pneumonia
and acute watery diarrhea respectively and were treated by
unqualified medical practitioners. Due to hemolysis and
clotting (162 in baseline and 131 in endline), hemoglobin
results were available for 818 children at baseline and 511
children at endline. The study profile is illustrated in
Fig. 1.
Statistical analysis
All data were entered into the computer after carefully
cross-checked and used double data entry method.
Fig. 1 Overall study profile
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Statistical analyses were done using STATA (Version 13.1;
StataCorp, College Station, Texas, USA). Statistical signifi-
cance was defined as p < 0.05. The distributions of data
were checked for normality by using histogram, QQ plot
and kurtosis & skewness. We compared baseline charac-
teristics between MNP groups using Student’s t tests,
Pearson chi-square tests and Mann–Whitney U test. Both
parametric and nonparametric approaches were used for
analyses and reported as medians and interquartile ranges,
or mean and standard division.
To explore the effect of 4 months MNP supplemen-
tation (TE) on hemoglobin level, we carried out the
following analysis:
Calculation of crude % enhancement in hemoglobin level
The 4 months MNP supplementation effect was calcu-
lated by the following formula:
TE: [(B −A) − (D − C)]
Where, A = baseline mean value for the 4 months
MNP supplementation group; B = endline mean value
for the 4 months MNP supplementation group; C =
baseline mean value for the 2 months MNP supplemen-
tation group; D = endline mean value for the 2 months
MNP supplementation group.
The percent enhancement by 4 months MNP supple-
mentation calculated as:
[(TE/A) * 100]
To assess the effect of the 4 months MNP supplemen-
tation we used difference-in-difference technique is as
follows:
Yit = β0 + β1 Time + β2 Group + δ (Time × Group)
+ β3 X + ε
Where,
Yit = Outcome variable of interest for individual i at
time t
Time = (1) if endline and (0) if baseline
Group = (1) if 4 months MNP supplementation and (0)
if 2 months MNP supplementation
δ = The effect of the 4 months MNP supplementation
X = Other covariates
ε = Error term
Anemia was defined as hemoglobin less than 11 g/dl.
To compare morbidity episodes between the groups we
used Incidence rate ratio (IRR) with generalized linear
models with a Poisson distribution. We also compared
these morbidity episodes with the similar data from
MAL-ED birth cohort children of the same community
who were followed since birth and not provided with
MNP supplementation. This comparison group was cat-
egorized in different age groups to match with 2 months
and 4 months supplementation groups and IRRs were
calculated after adjusting all possible confounders and
compared over a period of 4 months.
Ethics, consent and permissions
The research protocol was approved by the Research
Review Committee and the Ethical Review Committee of
International Centre for Diarrhoeal Disease Research,
Bangladesh (protocol number: PR-2008–020). Eligible
children were enrolled in the study after collecting in-
formed written consent from their parent/guardian.
Results
Our analysis showed two months supplementation group
had more numbers of older, underweight and wasted
children in the baseline (Table 1). Initiation of breast feed-
ing within 1 h of birth was higher among children with
4 months MNP supplementation. Thirty percent of the
children were introduced to soft and semisolid food before
6 months of age. More children in 2 months MNP group
received vitamin A supplementation through the govern-
ment program in comparison to 4 months MNP group.
Similar baseline findings were also observed among the
children who’s data were not analyzed due to unavailable
Hb data. Adherence to MNP supplementation between
2 months and 4 months MNP groups was similar, where
the percentages of good adherence were 85.16 % and
86.90 % for 2 months and 4 months groups, respectively.
Here good adherence means consumption of 75 % of
MNP sachets per child at the end of intervention period;
45 sachets for 2 months supplementation and 90 sa-
chets for 4 months supplementation. At the baseline,
hemoglobin levels were 10.57 ± 1.28 g/dl and 10.78 ±
1.35 g/dl for 2 months and 4 months supplementa-
tion groups, respectively. The difference was statisti-
cally significant (p < 0.05). At the end of intervention
period, hemoglobin levels were 10.65 ± 1.36 g/dl for
2 months supplementation group and 11.14 ± 1.11 g/dl for
4 months supplementation group. The change of im-
provement of hemoglobin level was significant (p < 0.05)
only after 4 months supplementation and there was 2.5%
point enhancement of hemoglobin level after 4 months
MNP supplementation which was observed in difference-
in-difference analysis. In the difference-in-difference ana-
lysis, we have adjusted for all the confounding variables
significant at baseline in the regression model which
include hemoglobin, gender, stunting, food security
and vitamin A supplementation status between two
age groups: 6–11 months and 12–23 months (Table 2).
Adjusted data showed that there was no difference
between the baseline Hb levels between 2 months
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and 4 months MNP supplementation groups for both
age groups and 6–11 months age group has a significant
improvement of 4 months supplementation (p < 0.05)
(Table 2).
In terms of change in anemia status, statistically sig-
nificant reduction of 9 % in the 2 months MNP group
and 12 % in the 4 months MNP group were noted, sug-
gesting that the intervention was effective in decreasing
prevalence of anemia in both the groups (Fig. 2). However,
no significant difference was observed in difference-in-
difference analysis between the supplementation groups
(p < 0.05).
Finally, we calculated morbidity episodes from the
surveillance data for each day up to 4 months, we ob-
served no difference in incidence rate ratios (IRR) for
diarrhea, cough and fever between 2 and 4 months MNP
supplementation groups. Moreover, IRR for acute lower
respiratory tract infection (ALRI) was significantly low in
4 month MNP supplementation group with IRR (95 % CI)
of 0.30 (0.22, 0.42). In comparison to MAL-ED children
without MNP supplementation, after adjusting gender,
nutritional status and food security status, for 6–11
months age group, there were higher incidences of diar-
rhoea, and ALRI in 2 months MNP supplementation
group and higher incidences of diarrhoea and cough in
4 months supplementation group. However, for the chil-
dren 12–17 months, apart from higher numbers of new
episodes of ALRI in 2 months supplementation group,
there were no differences in IRR of morbidity episodes
between MAL-ED cohort children and both the supple-
mentation groups. Moreover, for 18–24 months age,
children with 4 months MNP supplementation had sig-
nificant fewer episodes of fever and cough compared to
MAL-ED cohort children (Fig. 3 and Table 3).
Discussion
This study examined the effect of daily dosage of 2 months
and 4 months of multiple micronutrient powder sup-
plementations on hemoglobin status of children 6–23
Table 1 Baseline characteristics of the participating children in
each supplementation group






Age (Month)a 14 · 11 ± 5 · 25 12 · 20 ± 5 · 24 0 · 000
Sex, Female 207 (47.15) 191 (50.40) 0.355
Feeding history (%)
Initiation of breast feeding
<1 h
231 (52.74) 237 (62.53) 0.005
Colostrum feeding 415 (94 · 53) 356 (93 · 93) 0.712
Introduction of soft and
semisolid food
< 3 months 45 (10 · 30) 32 (8 · 44) 0.418
3–5 months 87 (19.91) 83 (21.90)
5–7 months 279 (63 · 84) 249 (65.70)
> 7 months 26 (5 · 95) 15 (3.96)
Vitamin A in the last six
month
277 (63.10) 196 (51.72) 0 · 001
Nutritional Statusa
Weight for height z score −1 · 07 ± 1 · 17 −0 · 70 ± 1 · 16 0.000
Height for age z score −1 · 74 ± 1 · 25 −1 · 58 ± 1 · 18 0.053
Weight for age z score −1 · 70 ± 1 · 28 −1 · 38 ± 1 · 28 0.0004
Mother’s characteristic
Mother’s age (Year)a 24 · 87 ± 5 · 41 24 · 75 ± 4 · 73 0.725
Mother’s education (%)
No schooling 94 (21.41) 69 (18 · 21) 0.138
Primary incomplete 139 (31.66) 101 (26.65)
Primary complete 169 (38.50) 172 (45.38)
Secondary 37 (8.43) 37 (9.76)
Household characteristic
Food security status
Food secure 226 (51.48) 246 (64.91) 0.001
Mild food insecurity 52 (11.85) 37 (9.76)
Moderate food insecurity 95 (21.64) 64 (16.89)
Severe food insecurity 66 (15.03) 32 (8.44)
Asset indexb
Poorest 90 (20.50) 74 (19.53) 0.406
Poor 89 (20.27) 75 (19.79)
Middle 97 (22.10) 68 (17.94)
Rich 78 (17.77) 84 (22.16)
Richest 85 (19.36) 78 (20.58)
Monthly income US$
(1 US$ = 78 BDT)
≤ 64 106 (24.15) 72 (19.00) 0.079
65–128 246 (56.04) 226 (59.63)
Table 1 Baseline characteristics of the participating children in
each supplementation group (Continued)
129–192 41 (9.34) 50 (13.19)
> 192 46 (10.48) 31 (8.18)
Biochemical characteristic of
children
Hemoglobin (g/dl)a 10.57 ± 1.28 10.78 ± 1.35 0.023
aMean ± sd and used t-test
bAsset index: The household asset index was constructed using household
asset data obtained from the SES questionnaire. From this asset related
dichotomous variables, using polychoric principal components analysis in
STATA software to produce a common factor score for each household. After
ranking by their score, we divided first principal component score into quintile
to create 5 categories where first category represents poorest and fifth
category represents richest one
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months in a slum of Dhaka. The results of this study had
clearly shown the relative improvement of hemoglobin
level in the 4 months group but not in the 2 months
group, but significant reduction in prevalence of anemia
in both MNP supplementation groups.
There are limited numbers of published studies that
assessed the effect of MNP on anemia beyond 2 months
of daily supplementation [13]. The reduction in the preva-
lence of anemia in this study is in concordance with a
recently completed study which compared 2 months of
daily MNP supplementation with 3 months and 4 months
of flexible MNP supplementation in children under the
age of 24 months from Bangladesh [20] and observed
significant reduction in the prevalence of anemia across
all three intervention groups when compared to baseline
prevalence. In a cluster randomized study at rural Nepal
observed a significant improvement of hemoglobin status
after providing MNP to children 6–9 months old over a
period of 11 months in flexible doses [21]. Moreover, in a
community-based randomized trial in Ghana, significant
effect on reduction of anemia prevalence was observed
from daily dosage of MNP for 6 months among children
from 6 to 12 months of age [17]. The anemia prevalence
decreased from 30 % at 6 months to 18 % at 12 months
which is consistent with the current study. In another
study, Giovannini et al. assessed the effectiveness of daily
MNP supplementation on anemia and iron deficiency
status in Cambodian infants over a period of one year
[17]. At the end of the study period, MNP was found to
be comparable to iron drop in preventing and treating
Table 2 Change of hemoglobin level after MNP supplementation
Age
categories
Baseline Endline DID p-value % enhancement
by 4 months MNP
supplementation



































To assess the effect of the 4 months MNP supplementation we used difference-in-difference (DID) technique is as follows:
Yit = β0 + β1 Time + β2 Group + δ (Time × Group) + β3 Gender + β4 Food security + β5 Stunted + β6 (Vitamin A capsule given) + ε
Where,
Yit = Outcome variable of interest for individual i at time t
Time = (1) if endline and (0) if baseline
Group = (1) if 4 months MNP supplementation and (0) if 2 months MNP supplementation
δ = The effect of the 4 months MNP supplementation
ε = Error term
Effect of 4 months MNP supplementation (TE): [(B − A) − (D − C)] Where, A = baseline mean value for the 4 months MNP supplementation group; B = endline mean
value for the 4 months MNP supplementation group; C = baseline mean value for the 2 months MNP supplementation group; D = endline mean value for the
2 months MNP supplementation group. The percent enhancement by 4 months MNP supplementation is calculated as: [(TE/A) × 100]
Fig. 2 Change in anemia status between 2 months and 4 months MNP supplementation groups before and after intervention
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anemia as well as stabilizing plasma ferritin level. The
Cochrane review also found significant reduction of
anemia after both 2 months and more than 2 months
of MNP supplementation and the risk reduction was
higher after longer duration of MNP supplementation
(44 % vs 31 %) [14]. In multivariate analysis, when we
stratified the children in two age groups as 6–11 months
and 12–23 months; after adjustment of the confounders,
we observed that 4 months supplementation worked bet-
ter than 2 months in younger children. There has been
paucity of evidence to support this finding [22]. In Haiti,
Menon et al. 2007 observed the similar phenomena. They
provided MNP supplementation to 6–24 months age
children for 2 months and observed that older
children did not benefit from MNP to the same de-
gree as younger children did [22]. It could be due to
the fact that older children had low iron requirement
and more consumption of phytate containing cereals
that reduced iron absorption [23].
Finally, it should be noted that the relationship between
increased infection and iron supplementation is ambigu-
ous and debatable [24]. During infection, micro-organisms
require iron for their proliferation [25]. On the other
hand, iron is essential for host immunity which combats
infection [26]. A systematic review of 28 randomized con-
trolled studies showed no obvious harmful effect on the
overall incidence of infectious illnesses in children after
iron supplementation [27]. In this study we observed
Fig. 3 Comparison of incidence rate ratios (IRRs) of morbidity episodes during supplementation period
Table 3 Comparison of incidence rate ratios (IRRs) of morbidities for 4 months between the MNP supplementation groups and
children without MNP supplementation
Multiple micronutrient
powder
Diarrhea ALRI Cough Fever
IRR (95 % CI) p-value IRR (95 % CI) p-value IRR (95 % CI) p-value IRR (95 % CI) p-value
Age 6–11 months
Nonea Ref Ref Ref Ref
2 Months 1.28 (1.08, 1.51) 0.004 2.22 (1.30, 3.80) 0.003 1.08 (0.97, 1.21) 0.175 1.04 (0.92, 1.17) 0.561
4 Months 1.26 (1.08, 1.46) 0.003 0.94 (0.52, 1.69) 0.839 1.11 (1.01, 1.23) 0.040 1.03 (0.92, 1.15) 0.586
Age 12–17 months
Nonea Ref Ref Ref Ref
2 Months 1.00 (081, 1.22) 0.978 1.75 (1.15, 2.64) 0.008 1.05 (0.92, 1.19) 0.485 0.97 (0.84, 1.12) 0.691
4 Months 0.94 (0.76, 1.17) 0.579 0.62 (0.35, 1.09) 0.098 0.98 (0.85, 1.11) 0.750 0.95 (0.81, 1.10) 0.482
Age 18–24 months
Nonea Ref Ref Ref Ref
2 Months 0.81 (0.61, 1.01) 0.062 4.20 (2.32, 7.62) 0.000 0.92 (0.80, 1.07) 0.273 0.87 (0.75, 1.01) 0.075
4 Months 0.83 (0.65, 1.07) 0.149 0.76 (0.28, 2.08) 0.598 0.83 (0.70, 0.98) 0.024 0.70 (0.58, 0.84) 0.000
IRR estimated with generalized linear models with a Poisson distribution. IRR means incidence rate ratio. All are adjusted by gender, stunting, underweight
wasting and food security status
aNone: Morbidity surveillance data from MAL-ED birth cohort children (n = 213) without MNP supplementation from the same age group
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significantly fewer episodes of infectious morbidity in chil-
dren with 4 months MNP supplementation when com-
pared to 2 months MNP supplementation. This finding is
in contrast to a study conducted in Zanzibar [28] and
Pakistan [29] where they found significantly increased
number of morbidity episodes after MNP consumption.
However, it should be noted that the Zanzibar study did
not find any significant adverse events associated with
MNP consumption in the 6–11 months group and in the
Pakistan trial, incidence of febrile illness or admission to
hospital for diarrhea and respiratory problems did not
differ between the MNP and control groups. When we
compared the IRR of morbidity with the comparison
group (MAL-ED cohort), the result was mixed and incon-
clusive. For younger children (6-11months), comparison
group was better and 4 months supplementation group
was middle in terms of fewer numbers of episodes. Mor-
bidity episodes were similar for 12–17 months children
across all three comparators. And for older children
(18–24 months), 4 months MNP group was better,
comparison MAL-ED cohort was middle and 2 months
MNP group was worse. Relatively fewer episodes of
morbidity among the comparison children at younger
age could be explained by the fact that the MAL-ED
children were recruited as healthy newborns, so better
immunity, hence fewer chances of infectious morbid-
ities [30]. Moreover, continuous interaction with the
mothers and the research staff from the rigorous data
collection in MAL-ED cohort study might responsible
for “Hawthrone effect” resulted in reduced morbidity
episodes [16, 21].
There are several limitations in this study. The study
was not a randomized controlled trial because the ori-
ginal study was not designed to assess the efficacy of
MNP supplementation at different duration. Moreover,
the duration between the baseline and endline blood col-
lection for the supplementation groups were also different.
Conclusion
Prevalence of anemia improved after both 2 months and
4 months MNP supplementation. However, 4 months
MNP supplementation was more effective in improving
hemoglobin status. Additionally, no additional infectious
morbidities were observed after 4 months supplementa-
tion. In areas with high burden of anemia, MNP supple-
mentation for a period for 4 months would most likely
be beneficial to combat the existing high prevalence of
childhood anemia.
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